Related Experiment Video
Updated: Jul 13, 2026

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
Published on: July 16, 2012
HCV structural proteins interfere with interferon-alpha Jak/STAT signalling pathway
Esther Luquin1, Esther Larrea, Maria P Civeira
1Division of Hepatology and Gene Therapy (CIMA), University of Navarra, Pamplona, Spain.
Insights
Hepatitis C virus (HCV) structural proteins block interferon-alpha signaling, hindering viral clearance. This study reveals how HCV evades the interferon system, impacting chronic hepatitis C treatment effectiveness.
Area of Science:
- Virology
- Immunology
- Hepatology
Background:
- Hepatitis C virus (HCV) establishes persistent infections effectively.
- Current treatments (interferon-alpha and ribavirin) are often ineffective for chronic hepatitis C.
- HCV is known to interfere with interferon-alpha signaling pathways, promoting viral persistence.
Purpose of the Study:
- To investigate how Hepatitis C virus (HCV) structural and non-structural proteins affect the Jak/STAT pathway.
- To analyze the impact of HCV proteins on interferon-alpha-induced antiviral activity.
- To understand the mechanisms by which HCV evades the interferon system.
Main Methods:
- Utilized the HCV genomic and subgenomic replicon system in Huh7 cells.
- Assessed the activation of the Jak/STAT pathway by interferon-alpha and interferon-gamma.
- Measured the transcriptional activity and antiviral effects of interferon-alpha.
Main Results:
- Interferon-alpha-mediated STAT activation was blocked in cells with the genomic replicon, but not the subgenomic replicon.
- IFN-alpha's antiviral activity and transcriptional effects were significantly reduced in cells harboring the genomic replicon.
- IFN-gamma-stimulated STAT phosphorylation remained unaffected.
Conclusions:
- HCV structural proteins are crucial in enabling the virus to escape the host's interferon-mediated immune response.
- Understanding this mechanism is vital for developing more effective therapies against chronic Hepatitis C.
- The findings highlight a key viral strategy for immune evasion.
Abstract:
Hepatitis C virus (HCV) is remarkably efficient at establishing persistent infection. The current treatment with IFN-alpha given alone or in combination with ribavirin is ineffective in eliminating the virus in a large proportion of individuals with chronic hepatitis C. Recent data suggest that HCV blocks IFN-alpha signalling, an effect that facilitates viral persistence. We have used the HCV genomic and subgenomic replicon system to analyze the effect of structural and non-structural viral proteins on the activation of the Jak/STAT pathway and induction of antiviral activity by IFN-alpha. Our results show that IFN-alpha-mediated STAT activation (but not IFN-gamma-stimulated STAT phosphorylation) is blocked in Huh7 cell line containing the genomic replicon, while this is not observed in cells with the subgenomic replicon. In agreement with these findings, the transcriptional activity and the antiviral effect of IFN-alpha were significantly lower in cells harboring the genomic replicon than in cells with the subgenomic replicon. These results indicate that HCV structural proteins play an important role in the escape of HCV from the interferon system.
Related Concept Videos
The JAK-STAT Signaling Pathway
Inhibitors of Viral Protein Synthesis
Inhibitors of Virion Maturation and Assembly
Hepatitis
Inhibitors Of Virion Release
TGF - β Signaling Pathway

